CohBar to Present at the BIO-Europe Conference

MENLO PARK, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company update at the BIO-Europe Conference, being held virtually on October 26 - 29, 2020. This presentation will be available on demand for BIO-Europe attendees.

Click to view original post